Account
Inquiry
Tirzepatide pens contain a novel dual GIP and GLP-1 receptor agonist peptide that has shown promising results in metabolic research. Our pharmaceutical-grade tirzepatide is manufactured under strict quality control standards for research applications.
The tirzepatide pens we supply are formulated with 99.8% purity active pharmaceutical ingredient (API) and are provided in convenient vial packaging. Each box contains 10 vials of research-grade material suitable for laboratory studies.
As a professional manufacturer, we offer tirzepatide pens in bulk quantities for research institutions and pharmaceutical developers. Our production facility maintains cGMP standards to ensure batch-to-batch consistency and reliable performance in research settings.
Key advantages of our tirzepatide pens include rigorous quality testing, comprehensive analytical documentation, and flexible packaging options. We can provide custom formulations and labeling to meet specific research requirements.
The tirzepatide molecule (CAS 2023788-19-2) has demonstrated significant potential in metabolic disorder research. Our manufacturing process ensures high purity and stability of the peptide for reliable research outcomes.
All tirzepatide pens batches undergo multiple quality control tests including HPLC purity analysis, mass spectrometry confirmation, and sterility testing. Complete certificates of analysis are provided with each shipment.
For research institutions requiring large quantities, we offer competitive pricing on bulk orders of tirzepatide pens with guaranteed purity and consistent quality. Our technical team can provide support for research protocol development.
Note: This product is for research use only. Not for human consumption or diagnostic use. Proper safety protocols should be followed when handling research peptides.
